Bright Rex 4
4 · Foamix Pharmaceuticals Ltd. · Filed May 10, 2018
Insider Transaction Report
Form 4
Bright Rex
Director
Transactions
- Award
Options
2018-05-08+24,947→ 24,947 total(indirect: See footnote)Exercise: $5.06Exp: 2028-05-08→ Ordinary Shares (24,947 underlying)
Footnotes (3)
- [F1]Each option represents a contingent right to purchase one ordinary share of the issuer.
- [F2]The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 8, 2019.
- [F3]The options are held by the Bright Family Trust whose trustees are Rex and Marilyn Bright.